Delivery Order SPE2DR25D2007-SPE2DR26FM27E
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on December 3, 2025, for the supply of Zepbound 10 mg/0.5 ml pen injections with a ceiling value of $3,623.56. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of December 4, 2025. The contract is performed from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on October 22, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injections. This firm fixed-price delivery order, valued at $21,693.46, represents a non-competitive set-aside procurement and is scheduled for completion by October 23, 2025. The award will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $38,628.48 delivery order contract by the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract utilizes firm fixed pricing and carries an ultimate completion date of August 27, 2025. This award represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's broader relationship...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $10,895.51 by the Defense Logistics Agency (DLA) on December 8, 2025, for the supply of Zepbound 12.5 mg/0.5 ml pen injections with a completion date of December 9, 2025. The award is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $4,042.74 by the Defense Logistics Agency (DLA) for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with an ultimate completion date of December 11, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to a location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $36,921.15 by the Defense Logistics Agency (DLA) on November 12, 2025, for the supply of Zepbound 15 mg/0.5 mL pens. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of November 13, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,459.86 by the Defense Logistics Agency on September 15, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections (0.5 mL). The contract is classified as a firm fixed price delivery order with an ultimate completion date of September 16, 2025, and will be performed at the company's location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation applied. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $54,200.70 on December 10, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injections. This is a firm fixed-price, competitively awarded contract with a completion date of December 11, 2025, and represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at the contractor's Conshohocken, Pennsylvania location,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injections. This firm fixed-price delivery order, valued at $25,347.85, represents the company's continued role as a critical pharmaceutical supplier to federal military and healthcare systems. The order is expected to be completed by December 15, 2025, with fulfillment occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The...
- The Defense Logistics Agency awarded a $1,107.42 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pen injections. This is a non-set-aside award with an ultimate completion date of December 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract executed under AmerisourceBergen's larger indefinite delivery contract...
- SPE2DR25D2007Indefinite Delivery Contract
- SPE2DR25D2007-SPE2DR26FM27EDelivery Order
AmerisourceBergen Drug Corp was awarded a $46,570.98 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on December 16, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injections. The award, which is not set-aside and issued as a competitive delivery order, is scheduled for completion by December 17, 2025, with fulfillment occurring at the contractor's Conshohocken, Pennsylvania facility. This delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government, particularly supporting military and veteran healthcare systems. This contract award is a child order issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The parent IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's consistent receipt of competitively awarded delivery orders across diverse therapeutic domains, including diabetes medications, demonstrates the contractor's capability to meet federal medical procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $46.6k | 12/15/25 |